| Literature DB >> 7210604 |
D Voak, S Sacks, T Alderson, F Takei, E Lennox, J Jarvis, C Milstein, J Darnborough.
Abstract
A monoclonal anti-A antibody has been evaluated and found suitable for use as a potent routine ABO grouping reagent, without the use of additives. The IgM anti-A (MH2/6D4) is secreted into the tissue culture supernatant by a permanent line of cloned cells derived by fusion of anti-A producing spleen cells and a mouse myeloma cell line. This is a cost-effective reagent which should reduce production costs by over 50%. This reagent has the advantages inherent in monoclonal antibodies among them the availability of unlimited quantities of unvarying antibody of known properties.Entities:
Mesh：
Substances：
Year: 1980 PMID： 7210604 DOI： 10.1111/j.1423-0410.1980.tb01848.x
Source DB: PubMed Journal: Vox Sang ISSN： 0042-9007 Impact factor: 2.144